NASDAQ:SBRA - Sabra Health Care REIT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $19.50
  • Forecasted Upside: 23.50 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$15.79
▼ -0.08 (-0.50%)

This chart shows the closing price for SBRA by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Sabra Health Care REIT Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for SBRA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for SBRA

Analyst Price Target is $19.50
▲ +23.50% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Sabra Health Care REIT in the last 3 months. The average price target is $19.50, with a high forecast of $21.00 and a low forecast of $17.00. The average price target represents a 23.50% upside from the last price of $15.79.

This chart shows the closing price for SBRA for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 5 investment analysts is to buy stock in Sabra Health Care REIT. This rating has held steady since February 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 1 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 5 hold ratings
  • 1 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 5 hold ratings
  • 1 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 5 hold ratings
  • 1 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/21/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/20/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
9/19/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/13/2021JMP SecuritiesLower Price TargetMarket Outperform$24.00 ➝ $20.00Low
5/21/2021BMO Capital MarketsUpgradeMarket Perform ➝ Outperform$20.00 ➝ $21.00Low
5/9/2021Stifel NicolausUpgradeHold ➝ Buy$17.00 ➝ $21.00Low
1/13/2021MizuhoDowngradeBuy ➝ Neutral$18.00Low
1/13/2021Jefferies Financial GroupUpgradeHold ➝ Buy$17.00 ➝ $20.00Low
1/7/2021BMO Capital MarketsUpgradeUnderperform ➝ Market Perform$19.00Low
12/15/2020Smith Barney CitigroupBoost Price Target$14.00 ➝ $17.00Medium
12/3/2020JMP SecuritiesUpgradeMarket Perform ➝ Outperform$24.00Medium
10/2/2020MizuhoBoost Price TargetBuy$14.00 ➝ $16.00High
9/1/2020Stifel NicolausReiterated RatingHold$15.00High
7/2/2020CitigroupBoost Price TargetNeutral$10.00 ➝ $14.00Low
6/23/2020ScotiabankUpgradeSector Underperform ➝ Sector Perform$12.00 ➝ $15.00Medium
6/22/2020Wells Fargo & CompanyBoost Price TargetEqual Weight$13.00 ➝ $14.00Low
6/8/2020JMP SecuritiesInitiated CoverageMarket PerformLow
5/18/2020Berenberg BankUpgradeHold ➝ Buy$15.00High
4/23/2020SunTrust BanksReiterated RatingHold$15.00Medium
4/7/2020CitigroupLower Price TargetNeutral$20.00 ➝ $10.00High
3/26/2020Wells Fargo & CompanyLower Price TargetEqual Weight$22.00 ➝ $10.50Medium
3/23/2020Bank of AmericaDowngradeNeutral ➝ UnderperformMedium
2/26/2020MizuhoUpgradeNeutral ➝ Buy$22.00Low
2/6/2020BarclaysLower Price TargetOverweight$26.00 ➝ $25.00Low
2/5/2020Berenberg BankInitiated CoverageHold$22.00Medium
12/19/2019MizuhoInitiated CoverageNeutral$22.00Medium
12/18/2019CitigroupUpgradeSell ➝ Neutral$20.00High
10/14/2019Bank of AmericaInitiated CoverageNeutralLow
9/27/2019JMP SecuritiesBoost Price TargetMarket Outperform$22.00 ➝ $23.00Low
9/23/2019CitigroupDowngradeNeutral ➝ Sell$18.00 ➝ $20.00Low
9/3/2019BarclaysInitiated CoverageOverweight$24.00High
2/26/2019BMO Capital MarketsDowngradeMarket Perform ➝ UnderperformMedium
1/14/2019BMO Capital MarketsReiterated RatingHold$17.00Medium
12/18/2018SunTrust BanksDowngradeBuy ➝ HoldMedium
11/20/2018CitigroupSet Price TargetHold$18.00Low
11/16/2018Bank of AmericaDowngradeNeutral ➝ Underperform$23.00 ➝ $21.00Medium
11/16/2018Raymond JamesDowngradeOutperform ➝ Market PerformMedium
11/13/2018MizuhoDowngradeBuy ➝ Neutral$21.00Medium
9/18/2018BMO Capital MarketsInitiated CoverageMarket Perform$24.00Medium
8/17/2018Raymond JamesBoost Price TargetOutperform ➝ Buy$22.00 ➝ $24.00Medium
8/13/2018MizuhoReiterated RatingBuy$26.00Low
7/18/2018Jefferies Financial GroupReiterated Rating$21.91$22.00Low
6/11/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$21.00 ➝ $22.00Low
6/4/2018Cantor FitzgeraldReiterated RatingBuy$25.00Medium
6/1/2018Raymond JamesUpgradeOutperformLow
5/21/2018Raymond JamesUpgradeMarket Perform ➝ OutperformHigh
5/14/2018JMP SecuritiesBoost Price TargetOutperform ➝ Outperform$19.00 ➝ $21.00Low
5/9/2018Cantor FitzgeraldReiterated RatingBuy$25.00High
3/26/2018Bank of AmericaUpgradeUnderperform ➝ Neutral$20.00Medium
3/20/2018Wells Fargo & CompanyLower Price TargetMarket Perform ➝ Market Perform$24.00 ➝ $19.00Medium
3/14/2018MizuhoUpgradeNeutral ➝ Buy$24.00Low
2/23/2018MizuhoSet Price TargetHold$18.00Low
2/22/2018Stifel NicolausReiterated RatingHold ➝ Hold$22.00 ➝ $21.00Medium
1/22/2018SunTrust BanksSet Price TargetBuy$22.00Low
12/21/2017Jefferies Financial GroupReiterated RatingBuy ➝ HoldLow
12/13/2017Raymond JamesReiterated RatingHoldMedium
11/3/2017SunTrust BanksReiterated RatingBuy$25.00N/A
11/3/2017Stifel NicolausReiterated RatingHold$22.00N/A
10/9/2017SunTrust BanksReiterated RatingBuy$30.00N/A
10/4/2017MizuhoReiterated RatingHold$23.00Low
9/28/2017Cantor FitzgeraldReiterated RatingBuy$30.00Low
9/27/2017Jefferies Financial GroupReiterated RatingBuy$25.00 ➝ $24.00Low
9/25/2017Capital One FinancialInitiated CoverageEqual Weight$24.00Low
9/11/2017MizuhoUpgradeUnderperform ➝ Neutral$23.00 ➝ $24.00Medium
9/8/2017Bank of AmericaBoost Price TargetUnderperform$21.00 ➝ $22.00Low
9/8/2017Cantor FitzgeraldReiterated RatingBuy$30.00Medium
9/5/2017JMP SecuritiesUpgradeMarket Perform ➝ Outperform$23.00Low
8/15/2017Jefferies Financial GroupUpgradeHold ➝ Buy$25.00Medium
7/28/2017Stifel NicolausReiterated RatingHold$26.00Medium
7/10/2017MizuhoDowngradeNeutral ➝ Underperform$25.00 ➝ $23.00Low
7/9/2017Jefferies Financial GroupReiterated RatingHold$28.00 ➝ $25.00Low
6/28/2017MizuhoReiterated RatingNeutralLow
5/12/2017Jefferies Financial GroupReiterated RatingHold$28.00Low
5/9/2017Canaccord GenuityReiterated RatingHold$26.00Low
5/8/2017Cantor FitzgeraldReiterated RatingBuy$30.00High
2/28/2017Cantor FitzgeraldBoost Price TargetOverweight$25.00 ➝ $30.00N/A
2/27/2017Stifel NicolausBoost Price TargetHold$24.00 ➝ $26.00N/A
2/27/2017MizuhoReiterated RatingNeutral ➝ Neutral$22.00 ➝ $28.00N/A
1/31/2017Jefferies Financial GroupReiterated RatingHold$25.00N/A
12/28/2016JMP SecuritiesReiterated RatingMarket PerformN/A
10/23/2016Jefferies Financial GroupReiterated RatingHold$25.00N/A
10/10/2016MizuhoReiterated RatingNeutral$23.00N/A
(Data available from 9/20/2016 forward)

News Sentiment Rating

1.52 (Strong Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/22/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/24/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/23/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
6/22/2021
  • 7 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/22/2021
  • 4 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/21/2021
  • 14 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/20/2021

Current Sentiment

  • 14 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Sabra Health Care REIT logo
Sabra Health Care REIT, Inc. engages in managing and investing in healthcare-related real estate properties. It focuses on the acquisition, financing and owning real estate property to be leased to third party tenants in the healthcare sector. The company was founded on May 10, 2010 and is headquartered in Irvine, CA.
Read More

Today's Range

Now: $15.79
Low: $15.68
High: $15.96

50 Day Range

MA: $17.01
Low: $15.40
High: $18.68

52 Week Range

Now: $15.79
Low: $12.86
High: $19.01

Volume

2,828,600 shs

Average Volume

1,765,047 shs

Market Capitalization

$3.49 billion

P/E Ratio

N/A

Dividend Yield

7.60%

Beta

1.5

Frequently Asked Questions

What sell-side analysts currently cover shares of Sabra Health Care REIT?

The following Wall Street research analysts have issued stock ratings on Sabra Health Care REIT in the last twelve months: BMO Capital Markets, Jefferies Financial Group Inc., JMP Securities, Mizuho, Smith Barney Citigroup, Stifel Nicolaus, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for SBRA.

What is the current price target for Sabra Health Care REIT?

6 Wall Street analysts have set twelve-month price targets for Sabra Health Care REIT in the last year. Their average twelve-month price target is $19.50, suggesting a possible upside of 23.5%. BMO Capital Markets has the highest price target set, predicting SBRA will reach $21.00 in the next twelve months. Smith Barney Citigroup has the lowest price target set, forecasting a price of $17.00 for Sabra Health Care REIT in the next year.
View the latest price targets for SBRA.

What is the current consensus analyst rating for Sabra Health Care REIT?

Sabra Health Care REIT currently has 1 hold rating and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe SBRA will outperform the market and that investors should add to their positions of Sabra Health Care REIT.
View the latest ratings for SBRA.

What other companies compete with Sabra Health Care REIT?

How do I contact Sabra Health Care REIT's investor relations team?

Sabra Health Care REIT's physical mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The real estate investment trust's listed phone number is (888) 393-8248 and its investor relations email address is [email protected] The official website for Sabra Health Care REIT is www.sabrahealth.com.